
Find me there → https://teapawt.net/t.co/rkmbZtblnj Group Leader @gustaveroussy • Alumna @thecrick #inflammation #cancer #RAS #prevention
London
Joined February 2012
- Tweets795
- Following495
- Followers379
- Likes1.2K
Sophie de Carné retweeted
L’Université Paris-Saclay et sa communauté universitaire (Facultés, IUT, Écoles, Universités membres associés) ont décidé de mettre fin à leur activité sur le réseau X (anciennement Twitter).
Retrouvez-nous sur BlueSky : univparissaclay.bsky.social
I’m thrilled to share that I’ve started a new position as Junior Group Leader at @GustaveRoussy, leading the Inflammation and Cancer Plasticity Lab.
My lab will study the effects of systemic factors associated with metabolic diseases on cancer initiation and progression.
As I settle into this new chapter, I’ve decided to leave X/Twitter to explore more positive platforms. You can find me on BlueSky 🦋 @sdecarne.bsky.social and on LinkedIn.
Sophie de Carné retweeted
Excited to co-organize the virtual @EACRnews @Boehringer Conference: Drugging & Regulating the MAP Kinase Pathway! Submit an abstract or join us. Please RT and share with others.
Details & registration:
eacr.org/conference/boehring…
Sophie de Carné retweeted
Not for the first time, all Nobel Prizes in scientific disciplines this year have been awarded to men
Sophie de Carné retweeted
Study of new personalised cancer therapies could ‘transform’ how the disease is treated theguardian.com/science/2024…
Sophie de Carné retweeted
How can we extend responses to KRASG12C drugs? Out now in @NatureComms, combining Revolution Medicines’ RAS(ON) G12C-selective inhibitor with a SHP2 inhibitor and immune checkpoint blockade to study their effects on KRAS-mutant lung tumours of varying immunogenicities.
Sophie de Carné retweeted
✨ Elles sont médecins, chercheuses, scientifiques à Gustave Roussy ✨
Dr Elsa Bernard est cheffe de groupe de l'équipe oncologie clinique computationnelle à @GustaveRoussy.
Découvrir son portrait ⤵
Sophie de Carné retweeted
Beyond excited to share our work on the reciprocal interaction between metastatic cancer cells and AT2 cells now published @Dev_Cell ! 🧵 [1/15]
cell.com/developmental-cell/…
Sophie de Carné retweeted
The data are clear: taking sex and gender into account in research and using that knowledge to change health care could benefit billions of people go.nature.com/3K6LAe0
Sophie de Carné retweeted
Excited to share our review on “Analyzing the functional effects of DNA variants with gene editing” @CellRepMethods
sciencedirect.com/science/ar…
With recent advancements in saturation genome editing, base editing and prime editing, this is a rapidly progressing and exciting field!
Sophie de Carné retweeted
Check out our latest paper science.org/doi/10.1126/scie…. Congratulations to @giampazolias who led the work. Thanks to very many who helped. Great collaboration with Tine Jess and @RominaGoldszmid labs. Tweetorial will follow soon.
Scientists at the Crick, @theNCI and @aalborg_uni found that vitamin D encourages the growth of a type of gut bacteria in mice that improves cancer immunity.
The @CR_UK -funded work includes Crick researchers @ReiseSousaLab and (formerly) @giampazolias
crick.ac.uk/news-and-reports…
Sophie de Carné retweeted
Our paper is out! Excited to be part of such an amazing team unravelling the complexities of lung tumour/TME coevolution in #TRACERx Big thanks to all those involved in the project and who supported our work. Presented by @CharlesSwanton at #AACR24 Check out our Tweetorial below.
What is the role of the TME in lung cancer evolution? We are excited to share our new TRACERx paper “Spatial Architecture of Myeloid and T Cells Orchestrates Immune Evasion and Clinical Outcome in Lung Cancer” at #AACR24, out in @CD_AACR today rb.gy/q484j9 Tweetorial👇
Sophie de Carné retweeted
What is the role of the TME in lung cancer evolution? We are excited to share our new TRACERx paper “Spatial Architecture of Myeloid and T Cells Orchestrates Immune Evasion and Clinical Outcome in Lung Cancer” at #AACR24, out in @CD_AACR today rb.gy/q484j9 Tweetorial👇
Sophie de Carné retweeted
Delighted to share our review on the impact of oncogenic KRAS on the tumour immune microenvironment and the potential for combining KRAS inhibitory drugs with immunotherapies. @Cancer_Cell #OpenAccess @TheCrick @molina_arcas authors.elsevier.com/sd/arti…
Sophie de Carné retweeted
Visit of HERI Minister Sylvie Retailleau in London, at the occasion of the 1st 🇫🇷🇬🇧 dialog on Science & Technology Feb 28&29
3/5: Impressive visit to @TheCrick organised by @ucl . Wonderful welcome by @SirPaulNurse, visiting the amazing building, meeting scientists
Sophie de Carné retweeted
Why is science a core subject? Our animation aimed at students aged 14 to 16 explains the key transferable skills gained from studying science and the relevance of science to all future careers. #NationalCareersWeek royalsociety.org/news-resour…
Sophie de Carné retweeted
People around the world have high levels of trust in scientists, and most want researchers to get more involved in policymaking, finds a global survey with more than 70,000 participants go.nature.com/4bBC3rU























